Detalhe da pesquisa
1.
Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection.
N Engl J Med
; 384(6): 541-549, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567193
2.
New viral vectors for infectious diseases and cancer.
Semin Immunol
; 50: 101430, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262065
3.
Adenovirus vectors activate Vδ2+ γδT cells in a type I interferon-, TNF-, and IL-18-dependent manner.
Eur J Immunol
; 52(5): 835-837, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34958459
4.
Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19.
Mol Ther
; 29(8): 2412-2423, 2021 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895322
5.
Characterizing Hepatitis C Virus-Specific CD4+ T Cells Following Viral-Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure.
Hepatology
; 72(5): 1541-1555, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32012325
6.
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.
N Engl J Med
; 374(17): 1635-46, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25629663
7.
Antigen-specific CD8 T cells in cell cycle circulate in the blood after vaccination.
Scand J Immunol
; 89(2): e12735, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488973
8.
Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy.
J Urban Health
; 95(1): 99-110, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29204843
9.
Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral.
Hepatology
; 63(5): 1442-54, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26513111
10.
Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans.
Hepatology
; 63(5): 1455-70, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26474390
11.
Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes.
Eur J Immunol
; 45(1): 309-16, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25263407
12.
Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
J Virol
; 88(10): 5502-10, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24599994
13.
T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee.
Hepatology
; 60(5): 1531-40, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24975498
14.
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.
J Immunol
; 190(6): 2720-35, 2013 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23390298
15.
Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.
Mol Ther
; 22(5): 1039-47, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24476798
16.
Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors.
Mol Ther Oncol
; 32(1): 200760, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38596303
17.
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines.
Int J Biol Macromol
; 262(Pt 1): 129926, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331062
18.
Role of IL28B gene polymorphism and cell-mediated immunity in spontaneous resolution of acute hepatitis C.
Clin Infect Dis
; 57(6): 803-11, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23784926
19.
Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.
J Hepatol
; 59(2): 221-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23587473
20.
Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus.
Gastroenterology
; 143(4): 1048-60.e4, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22705008